Enterome

Enterome

Enterome

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

2012Active33Paris, France
Rate

About

Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Their pioneering approach leverages a unique ability to decode the interaction between the gut microbiome and the immune system, using a proprietary Mimicry platform to identify novel therapeutics from a vast database of gut microbiome proteins. The company is advancing pipelines of drug candidates, including OncoMimics™ for cancer and EndoMimics™ for immune diseases.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to Enterome?

People comparing tools land here. Get listed beside these.

Copy Enterome's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
enterome.com
Headquarters
Paris, France
Founded
2012
Founders
Marie-Laure Bouttier, Pierre Belichard
Employees
33
Total funding
$123.9M (Later Stage VC)
Business model
B2B

Funding rounds

Funding rounds raised by Enterome
DateRoundAmountLead investors
12 Jun 2025Later Stage VC$19M
30 Oct 2023Accelerator/Incubator$3M
25 Jun 2020Series E$52.6M
1 Jan 2018Series D$38.5M
1 May 2014Series B$10.8MSeventure Partners

Benchmarking

See how your site ranks against 16,849 startups

Enterome sits in the 55th percentile for Domain Rating. Check where yours lands, free.

Enterome has a Domain Rating of 46, the 55th percentile of 16,849 startups we track.

Scores

Measured, not editorial

46

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Above median

Check yours
48

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Above median

Scan yours
56

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Below median

PageSpeed
78

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Above median

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

Enterome scores 48. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when Enterome changes

Used Enterome? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Who owns Enterome?

Enterome is privately held, owned by its founders and investors. Seventure Partners has backed 3 of the 5 rounds on record since May 2014, ahead of OMNES Capital (2), so it is likely among the largest outside shareholders. Exact stakes are not public.

Are there companies like Enterome?

Yes. We list 6 companies like Enterome, including Moleculent, Moderna and BioNTech.

Is Enterome trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Enterome is 78 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Enterome raised?

Enterome has raised a total of $123.9M in funding. The most recent round on record is Later Stage VC.

How many employees does Enterome have?

Enterome has approximately 33 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for Enterome:

Company details: from public sources. Funding: 5 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch Enterome and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini